Actively Recruiting
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
Led by Ciceri Fabio · Updated on 2025-05-08
80
Participants Needed
2
Research Sites
79 weeks
Total Duration
On this page
Sponsors
C
Ciceri Fabio
Lead Sponsor
A
Azienda Ospedaliera Bianchi-Melacrino-Morelli
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is designed as a collection of biological samples of newly diagnosed acute myeloid leukemia (AML) patients treated in the clinical units involved. Samples of peripheral blood (PB) and bone marrow (BM) will be analyzed to determine the Inflammasome profile before and after a first-line chemotherapy treatment.
CONDITIONS
Official Title
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any gender
- Adults over 18 years old
- Newly suspected diagnosis of acute myeloid leukemia based on ELN2022 criteria
- Able to understand the study and consent form
- Willing to sign the informed consent form
- For retrospective participants: biological samples collected from adults diagnosed with acute myeloid leukemia between 06/01/2006 and 06/01/2024 according to ELN2017 criteria
You will not qualify if you...
- Patients younger than 18 years old
- Patients unable or unwilling to sign the informed consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
GOM Bianchi Melacrino Morelli
Reggio Calabria, Calabria, Italy, 89133
Actively Recruiting
2
IRCCS Ospedale San Raffaele
Milan, Milan, Italy, 20132
Actively Recruiting
Research Team
S
Sara Mastaglio, Haematologist MD
CONTACT
V
Vincenzo Mercurio, Ph.D Trial Office Coordinator
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here